Please enable JavaScript to continue using this application.

Compare $ABEO vs $VNDA | Chartloom

Compare

$ABEO vs $VNDA

Abeona Therapeutics Inc · Vanda Pharmaceuticals Inc

ABEO

Abeona Therapeutics Inc

VNDA

Vanda Pharmaceuticals Inc

Compare $ABEO vs $VNDA

Comparing Abeona Therapeutics Inc and Vanda Pharmaceuticals Inc

ABEOAbeona Therapeutics Inc

VNDAVanda Pharmaceuticals Inc

ABEOAbeona Therapeutics Inc

Market cap

$282M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.20x

Rev growth (TTM)

6280.0%

YTD performance

-7.0%

52W performance

-10.8%

FCF yield

-29.0%

VNDAVanda Pharmaceuticals Inc

Market cap

$275M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.89x

Rev growth (TTM)

6.0%

YTD performance

-44.6%

52W performance

-16.3%

FCF yield

-55.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABEO

VNDA

Detailed metrics comparison

ABEO

Abeona Therapeutics Inc

VNDA

Vanda Pharmaceuticals Inc

Market Cap

ABEO$282M

VNDA$275M

Enterprise Value

ABEO$240M

VNDA$226M

Price

ABEO$4.94

VNDA$4.57

P/E Ratio

ABEON/A

VNDAN/A

P/S Ratio

ABEO11.03x

VNDA1.27x

EV/Sales

ABEO9.42x

VNDA1.05x

EV/EBITDA

ABEO3.95x

VNDA183.49x

P/B Ratio

ABEO2.25x

VNDA1.29x

P/FCF Ratio

ABEON/A

VNDAN/A

EV/FCF

ABEO-2.95x

VNDA-1.48x

PEG Ratio

ABEON/A

VNDAN/A

Forward P/E (NTM)

ABEON/A

VNDAN/A

Forward P/S (NTM)

ABEO3.20x

VNDA0.89x

Revenue (TTM)

ABEO$26M

VNDA$216M

Revenue Growth (YoY)

ABEO6280.0%

VNDA6.0%

Forward Rev Growth

ABEO131.0%

VNDA35.6%

Gross Margin (TTM)

ABEO67.1%

VNDA93.7%

Operating Margin (TTM)

ABEO0.0%

VNDA0.0%

EBITDA Margin (TTM)

ABEO-316.6%

VNDA-82.1%

Net Margin (TTM)

ABEO-246.4%

VNDA-127.4%

FCF Margin (TTM)

ABEO-319.5%

VNDA-70.9%

Net Income (TTM)

ABEO$-63M

VNDA$-275M

FCF (TTM)

ABEO$-82M

VNDA$-153M

EPS (TTM)

ABEO-$1.10

VNDA-$4.56

ROE (TTM)

ABEO-4169.0%

VNDA-8495.0%

ROA (TTM)

ABEO-3036.0%

VNDA-5679.0%

ROIC (TTM)

ABEO-3719.0%

VNDA-8320.0%

Cash

ABEO$56M

VNDA$56M

Debt

ABEO$15M

VNDA$7M

Net Cash/Debt

ABEO$41M

VNDA$49M

Current Ratio (TTM)

ABEO6.63x

VNDA1.61x

Quick Ratio (TTM)

ABEO6.32x

VNDA1.40x

Debt/Equity (TTM)

ABEO0.12x

VNDA0.03x

Debt/Assets (TTM)

ABEO0.0%

VNDA0.0%

Interest Coverage (TTM)

ABEON/A

VNDAN/A

Net Debt/EBITDA (TTM)

ABEO0.00x

VNDA0.00x

Beta

ABEO1.45

VNDA0.69

52W Performance

ABEO-10.8%

VNDA-16.3%

YTD Performance

ABEO-7.0%

VNDA-44.6%

% from 52W High

ABEO-35.4%

VNDA-54.0%

% from 52W Low

ABEO23.5%

VNDA7.0%

Asset Turnover (TTM)

ABEO0.13x

VNDA0.45x

FCF Yield (TTM)

ABEO-29.0%

VNDA-55.7%

Earnings Yield (TTM)

ABEO-22.3%

VNDA-100.0%

Dividend Yield (TTM)

ABEON/A

VNDAN/A

Rule of 40

ABEO5,960.5

VNDA-64.9

EV/GP/RG

ABEO0.04

VNDA0.01

Ticker research

View ABEO research View VNDA research

Metric	ABEO Abeona Therapeutics Inc	VNDA Vanda Pharmaceuticals Inc
Market & Valuation
Market Cap	$282M	$275M
Enterprise Value	$240M	$226M
Price	$4.94	$4.57
P/E Ratio	N/A	N/A
P/S Ratio	11.03x	1.27x
EV/Sales	9.42x	1.05x
EV/EBITDA	3.95x	183.49x
P/B Ratio	2.25x	1.29x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.95x	-1.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.20x	0.89x
Revenue & Growth
Revenue (TTM)	$26M	$216M
Revenue Growth (YoY)	6280.0%	6.0%
Forward Rev Growth	131.0%	35.6%
Profitability
Gross Margin (TTM)	67.1%	93.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-316.6%	-82.1%
Net Margin (TTM)	-246.4%	-127.4%
FCF Margin (TTM)	-319.5%	-70.9%
Net Income (TTM)	$-63M	$-275M
FCF (TTM)	$-82M	$-153M
EPS (TTM)	-$1.10	-$4.56
ROE (TTM)	-4169.0%	-8495.0%
ROA (TTM)	-3036.0%	-5679.0%
ROIC (TTM)	-3719.0%	-8320.0%
Financial Health
Cash	$56M	$56M
Debt	$15M	$7M
Net Cash/Debt	$41M	$49M
Current Ratio (TTM)	6.63x	1.61x
Quick Ratio (TTM)	6.32x	1.40x
Debt/Equity (TTM)	0.12x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	0.69
52W Performance	-10.8%	-16.3%
YTD Performance	-7.0%	-44.6%
% from 52W High	-35.4%	-54.0%
% from 52W Low	23.5%	7.0%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.45x
FCF Yield (TTM)	-29.0%	-55.7%
Earnings Yield (TTM)	-22.3%	-100.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5,960.5	-64.9
EV/GP/RG	0.04	0.01
Ticker research	View ABEO research	View VNDA research

Valuation

P/S Ratio

VNDA

1.27x

ABEO

11.03x

EV/FCF

ABEO

-2.95x

VNDA

-1.48x

Growth & revenue

Revenue Growth TTM

ABEO

6280.0%

VNDA

6.0%

Forward Revenue Growth

ABEO

131.0%

VNDA

35.6%

Profitability & performance

Gross Margin

VNDA

93.7%

ABEO

67.1%

ROE

ABEO

-4169.0%

VNDA

-8495.0%

FCF Yield %

ABEO

-29.0%

VNDA

-55.7%

52-Week Performance

ABEO

-10.8%

VNDA

-16.3%

Detailed metrics comparison

ABEO

Abeona Therapeutics Inc

VNDA

Vanda Pharmaceuticals Inc

Market Cap

ABEO$282M

VNDA$275M

Enterprise Value

ABEO$240M

VNDA$226M

Price

ABEO$4.94

VNDA$4.57

P/E Ratio

ABEON/A

VNDAN/A

P/S Ratio

ABEO11.03x

VNDA1.27x

EV/Sales

ABEO9.42x

VNDA1.05x

EV/EBITDA

ABEO3.95x

VNDA183.49x

P/B Ratio

ABEO2.25x

VNDA1.29x

P/FCF Ratio

ABEON/A

VNDAN/A

EV/FCF

ABEO-2.95x

VNDA-1.48x

PEG Ratio

ABEON/A

VNDAN/A

Forward P/E (NTM)

ABEON/A

VNDAN/A

Forward P/S (NTM)

ABEO3.20x

VNDA0.89x

Revenue (TTM)

ABEO$26M

VNDA$216M

Revenue Growth (YoY)

ABEO6280.0%

VNDA6.0%

Forward Rev Growth

ABEO131.0%

VNDA35.6%

Gross Margin (TTM)

ABEO67.1%

VNDA93.7%

Operating Margin (TTM)

ABEO0.0%

VNDA0.0%

EBITDA Margin (TTM)

ABEO-316.6%

VNDA-82.1%

Net Margin (TTM)

ABEO-246.4%

VNDA-127.4%

FCF Margin (TTM)

ABEO-319.5%

VNDA-70.9%

Net Income (TTM)

ABEO$-63M

VNDA$-275M

FCF (TTM)

ABEO$-82M

VNDA$-153M

EPS (TTM)

ABEO-$1.10

VNDA-$4.56

ROE (TTM)

ABEO-4169.0%

VNDA-8495.0%

ROA (TTM)

ABEO-3036.0%

VNDA-5679.0%

ROIC (TTM)

ABEO-3719.0%

VNDA-8320.0%

Cash

ABEO$56M

VNDA$56M

Debt

ABEO$15M

VNDA$7M

Net Cash/Debt

ABEO$41M

VNDA$49M

Current Ratio (TTM)

ABEO6.63x

VNDA1.61x

Quick Ratio (TTM)

ABEO6.32x

VNDA1.40x

Debt/Equity (TTM)

ABEO0.12x

VNDA0.03x

Debt/Assets (TTM)

ABEO0.0%

VNDA0.0%

Interest Coverage (TTM)

ABEON/A

VNDAN/A

Net Debt/EBITDA (TTM)

ABEO0.00x

VNDA0.00x

Beta

ABEO1.45

VNDA0.69

52W Performance

ABEO-10.8%

VNDA-16.3%

YTD Performance

ABEO-7.0%

VNDA-44.6%

% from 52W High

ABEO-35.4%

VNDA-54.0%

% from 52W Low

ABEO23.5%

VNDA7.0%

Asset Turnover (TTM)

ABEO0.13x

VNDA0.45x

FCF Yield (TTM)

ABEO-29.0%

VNDA-55.7%

Earnings Yield (TTM)

ABEO-22.3%

VNDA-100.0%

Dividend Yield (TTM)

ABEON/A

VNDAN/A

Rule of 40

ABEO5,960.5

VNDA-64.9

EV/GP/RG

ABEO0.04

VNDA0.01

Ticker research

View ABEO research View VNDA research

Metric	ABEO Abeona Therapeutics Inc	VNDA Vanda Pharmaceuticals Inc
Market & Valuation
Market Cap	$282M	$275M
Enterprise Value	$240M	$226M
Price	$4.94	$4.57
P/E Ratio	N/A	N/A
P/S Ratio	11.03x	1.27x
EV/Sales	9.42x	1.05x
EV/EBITDA	3.95x	183.49x
P/B Ratio	2.25x	1.29x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.95x	-1.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.20x	0.89x
Revenue & Growth
Revenue (TTM)	$26M	$216M
Revenue Growth (YoY)	6280.0%	6.0%
Forward Rev Growth	131.0%	35.6%
Profitability
Gross Margin (TTM)	67.1%	93.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-316.6%	-82.1%
Net Margin (TTM)	-246.4%	-127.4%
FCF Margin (TTM)	-319.5%	-70.9%
Net Income (TTM)	$-63M	$-275M
FCF (TTM)	$-82M	$-153M
EPS (TTM)	-$1.10	-$4.56
ROE (TTM)	-4169.0%	-8495.0%
ROA (TTM)	-3036.0%	-5679.0%
ROIC (TTM)	-3719.0%	-8320.0%
Financial Health
Cash	$56M	$56M
Debt	$15M	$7M
Net Cash/Debt	$41M	$49M
Current Ratio (TTM)	6.63x	1.61x
Quick Ratio (TTM)	6.32x	1.40x
Debt/Equity (TTM)	0.12x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	0.69
52W Performance	-10.8%	-16.3%
YTD Performance	-7.0%	-44.6%
% from 52W High	-35.4%	-54.0%
% from 52W Low	23.5%	7.0%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.45x
FCF Yield (TTM)	-29.0%	-55.7%
Earnings Yield (TTM)	-22.3%	-100.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5,960.5	-64.9
EV/GP/RG	0.04	0.01
Ticker research	View ABEO research	View VNDA research